Destabilization of the retinoblastoma tumor suppressor by human papillomavirus type 16 E7 is not sufficient to overcome cell cycle arrest in human keratinocytes

Journal of Virology

Volumn 75, Issue 15, 2001, Pages 6737-6747

  Helt, A M ^a   Galloway, D A ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN; RECOMBINANT PROTEIN; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA DAMAGE; GENE INACTIVATION; GENE MUTATION; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN STABILITY; TUMOR SUPPRESSOR GENE; WART VIRUS;

BINDING SITES; BINDING, COMPETITIVE; CELL CYCLE; CELL CYCLE PROTEINS; CELLS, CULTURED; DNA DAMAGE; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; GENE EXPRESSION; HUMANS; KERATINOCYTES; MUTAGENESIS; NUCLEAR PROTEINS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PHOSPHOPROTEINS; PROTEINS; RECOMBINANT FUSION PROTEINS; RETINOBLASTOMA PROTEIN; RETINOBLASTOMA-LIKE PROTEIN P107; RETINOBLASTOMA-LIKE PROTEIN P130; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0034959651     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.15.6737-6747.2001     Document Type: Article

References (73)

1. Association of the human papillomavirus type 16 E7 protein with the S-phase-specific E2F-cyclin A complex
2. Ability of the HPV16 E7 protein to bind RB and induce DNA synthesis is not sufficient for efficient transforming activity in N1H3T3 cells
3. The region of the HPV E7 oncoprotein homologous to adenovirus E1a and SV40 large T antigen contains separate domains for Rb binding and casein kinase II phosphorylation
4. Differential regulation of the pocket domains of the retinoblastoma family proteins by the HPV16 E7 oncoprotein
5. Expression of the HPV16 E7 gene generates proliferation in stratified squamous cell cultures which is independent of endogenous p53 levels
6. E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway
7. Retinoblastoma protein recruits histone deacetylase to repress transcription
8. The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth
9. INK4a
10. p21 is a critical CDK2 regulator essential for proliferation control in Rb-deficient cells
11. Regulation of E2F through ubiquitin-proteasome-dependent degradation: Stabilization by the pRB tumor suppressor protein
12. Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product
13. Human papillomavirus type 16 E7 associates with a histone H1 kinase and with p107 through sequences necessary for transformation
14. Abrogation of growth arrest signals by human papillomavirus type 16 E7 is mediated by sequences required for transformation
15. Growth arrest by induction of p53 in DNA damaged keratinocytes is bypassed by human papillomavirus 16 E7
16. The retinoblastoma protein and BRG1 form a complex and cooperate to induce cell cycle arrest
17. The regulation of E2F by pRB-family proteins
18. Homologous sequences in adenovirus E1A and human papillomavirus E7 proteins mediate interaction with the same set of cellular proteins
19. A point mutational analysis of human papillomavirus type 16 E7 protein
20. Purification and characterization of a functionally homogeneous 60-kDa species of the retinoblastoma gene product
21. Independent regions of adenovirus E1A are required for binding to and dissociation of E2F-protein complexes
22. The E7 protein of human papillomavirus type 16 is phosphorylated by casein kinase Il
23. Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein
24. The E7 proteins of the nononcogenic human papillomavirus type 6b (HPV-6b) and of the oncogenic HPV-16 differ in retinoblastoma protein binding and other properties
25. The E6 and E7 genes of human papillomavirus type 6 have weak immortalizing activity in human epithelial cells
26. The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells
27. 1
28. pRB plays an essential role in cell cycle arrest induced by DNA damage
29. A role for histone deacetylase activity in HDAC1-mediated transcriptional repression
30. Degradation of E2F by the ubiquitin-proteasome pathway: Regulation by retinoblastoma family proteins and adenovirus transforming proteins
31. HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes
32. Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein
33. Regions of the retinoblastoma gene product required for its interaction with the E2F transcription factor are necessary for E2 promoter repression and pRb-mediated growth suppression
34. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins
35. The retinoblastoma gene product protects E2F-1 from degradation by the ubiquitin-proteasome pathway
36. Protein domains governing interactions between E2F, the retinoblastoma gene product, and human papillomavirus type 16 E7 protein
37. Identification of distinct roles for separate E1A domains in disruption of E2F complexes
38. Purification and characterization of human papillomavirus type 16 E7 protein with preferential binding capacity to the underphosphorylated form of retinoblastoma gene product
39. Cip1-mediated inhibition of cdk2
40. 1 growth arrest pathway in cells expressing the human papillomavirus type 16 E7 oncoprotein
41. Destabilization of the RB tumor suppressor protein and stabilization of p53 contribute to HPV type 16 E7-induced apoptosis
42. INK4a inactivation and telomerase activity are required to immortalize human epithelial cells
43. Structure of the retinoblastoma tumour-suppressor pocket domain bound to a peptide from HPV E7
44. Functional domains of adenovirus type 5 Ela proteins
45. Rb interacts with histone deacetylase to repress transcription
46. Retinoblastoma protein represses transcription by recruiting a histone deacetylase
47. Human papillomavirus type 16 E7 binds to the conserved carboxy-terminal region of the TATA box binding protein and this contributes to E7 transforming activity
48. The carboxyl-terminal zinc-binding domain of the human papillomavirus E7 protein can be functionally replaced by the homologous sequences of the E6 protein
49. Human papillomavirus type 18 E7 protein requires intact Cys-X-X-Cys motifs for zinc binding, dimerization, and transformation but not for Rb binding
50. Improved retroviral vectors for gene transfer and expression
51. The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes
52. Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product
53. Binding of the human E2F transcription factor to the retinoblastoma protein but not to cyclin A is abolished in HPV-16-immortalized cells
54. Identification of a novel retinoblastoma gene product binding site on human papillomavirus type 16 E7 protein
55. Structure-function analysis of the human papillomavirus type 16 E7 oncoprotein
56. The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A
57. Biological function of the retinoblastoma protein requires distinct domains for hyperphosphorylation and transcription factor binding
58. Degradation of the E7 human papillomavirus oncoprotein by the ubiquitin-proteasome system: Targeting via ubiquitination of the N-terminal residue
59. 1 control and immortalization
60. Anchorage-independent transcription of the cyclin A gene induced by the E7 oncoprotein of human papillomavirus type 16
61. Human papillomavirus (HPV) type 18 E7 protein is a short-lived steroid-inducible phosphoprotein in HPV-transformed cell lines
62. 1 cyclin-dependent kinases
63. 1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein
64. Human papillomavirus type 16 E6 and E7 oncogenes abrogate radiation-induced DNA damage responses in vivo through p53-dependent and p53-independent pathways
65. Mutations of the human papillomavirus type 16 E7 gene that affect transformation, transactivation and phosphorylation by the E7 protein
66. Mutational analysis of human papillomavirus type 16 E7 functions
67. The human papillomavirus E7 oncoprotein and the cellular transcription factor E2F bind to separate sites on the retinoblastoma tumor suppressor protein
68. Cell cycle-dependent disruption of E2F-p107 complexes by human papillomavirus type 16 E7
69. Sequential activation of cyclin E and cyclin A gene expression by human papillomavirus type 16 E7 through sequences necessary for transformation
70. 1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF
71. Papillomavirus infections - A major cause of human cancers
72. Allosteric activation of acid alpha-glucosidase by the human papillomavirus E7 protein
73. Modulation of type M2 pyruvate kinase activity by the human papillomavirus type 16 E7 oncoprotein